MED-ELs OPUS 2 Processor Receives FDA ApprovalBy Hearing Review - The Insider,
Publication Date: April 24, 2008
News item of the OPUS 2 cochlear implant speech processor by MED-EL. The OPUS 2, which has been approved by the US Food and Drug Administration, is a speech processor developed for bilaterally implanted listeners. It is operated by a remote-control unit, the FineTuner, which is designed to communicate with two speech processors. An integrated telecoil and a universal direct input for wireless FM and Bluetooth connection provide interaction with the surrounding environment. It features MED-ELs Fine Structure Processing (FSP) sound-coding strategy, which refers to detailed pitch and timing cues that facilitate listening to music or having conversations in noisy environments. A High Definition Continuous Interleaved Sampling (HD-CIS) coding strategy is also offered. The FSP strategy is approved for use by cochlear implant users with at least 6 months experience with the CIS or HD-CIS programming options. OPUS 2 weighs about 10 grams and has a thickness of 7 to 8.7 millimeters, and gets 3 to 5 days of use on a single set of disposable batteries.
Published by: Ascend Media LLC (Website:http://www.ascendmedia.com)
Link to text: http://www.hearingreview.com/insider/2008-04-24_07.asp